Life Science REIT (LABS) Competitors

Impact Healthcare REIT (LON:IHR) and Life Science REIT (LON:LABS) are both small-cap real estate companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, dividends, media sentiment, earnings, risk, valuation, institutional ownership and profitability.

Which has more risk and volatility, IHR or LABS?

Impact Healthcare REIT has a beta of 0.37, indicating that its share price is 63% less volatile than the S&P 500. Comparatively, Life Science REIT has a beta of 0.08, indicating that its share price is 92% less volatile than the S&P 500.

Do insiders & institutionals have more ownership in IHR or LABS?

59.5% of Impact Healthcare REIT shares are held by institutional investors. Comparatively, 67.3% of Life Science REIT shares are held by institutional investors. 9.3% of Impact Healthcare REIT shares are held by company insiders. Comparatively, 7.0% of Life Science REIT shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Does the media refer more to IHR or LABS?

In the previous week, Impact Healthcare REIT and Impact Healthcare REIT both had 1 articles in the media. Impact Healthcare REIT's average media sentiment score of 1.00 beat Life Science REIT's score of 0.59 indicating that Impact Healthcare REIT is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Impact Healthcare REIT	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Life Science REIT	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Is IHR or LABS a better dividend stock?

Impact Healthcare REIT pays an annual dividend of GBX 7 per share. Life Science REIT pays an annual dividend of GBX 2 per share and has a dividend yield of 5.0%. Impact Healthcare REIT pays out 6,363.6% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Life Science REIT pays out -17.7% of its earnings in the form of a dividend. Life Science REIT is clearly the better dividend stock, given its higher yield and lower payout ratio.

Is IHR or LABS more profitable?

Impact Healthcare REIT has a net margin of 88.90% compared to Life Science REIT's net margin of -198.99%. Impact Healthcare REIT's return on equity of 9.90% beat Life Science REIT's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Impact Healthcare REIT	88.90%	9.90%	4.30%
Life Science REIT	-198.99%	-14.53%	1.25%

Do analysts recommend IHR or LABS?

Life Science REIT has a consensus price target of GBX 46.50, suggesting a potential upside of 16.58%. Given Life Science REIT's stronger consensus rating and higher possible upside, analysts clearly believe Life Science REIT is more favorable than Impact Healthcare REIT.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Impact Healthcare REIT	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Life Science REIT	0 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.67

Which has stronger valuation & earnings, IHR or LABS?

Impact Healthcare REIT has higher revenue and earnings than Life Science REIT. Life Science REIT is trading at a lower price-to-earnings ratio than Impact Healthcare REIT, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Impact Healthcare REIT	£53.51M	0.00	£47.58M	£0.11	N/A
Life Science REIT	£20.41M	6.94	-£40.62M	-£11.28	-3.54

Summary

Impact Healthcare REIT beats Life Science REIT on 10 of the 16 factors compared between the two stocks.